Edition:
India

Jianmin Pharmaceutical Group Co Ltd (600976.SS)

600976.SS on Shanghai Stock Exchange

23.70CNY
19 Jan 2018
Change (% chg)

¥0.24 (+1.02%)
Prev Close
¥23.46
Open
¥23.46
Day's High
¥23.75
Day's Low
¥23.41
Volume
2,614,793
Avg. Vol
987,901
52-wk High
¥35.01
52-wk Low
¥23.00

Chart for

About

JIANMIN PHARMACEUTICAL GROUP CO., LTD., formerly Wuhan Jianmin Pharmaceutical Groups Co. Ltd, is a China-based company, principally engaged in the research and development, manufacture, wholesale and retailing of pharmaceuticals. The Company operates its businesses through two segments, including Pharmaceutical Industry and... (more)

Overall

Beta: 0.83
Market Cap(Mil.): ¥4,060.46
Shares Outstanding(Mil.): 153.40
Dividend: 0.10
Yield (%): 0.38

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.58
EPS (TTM): -- -- --
ROI: -- 14.84 10.60
ROE: -- 16.32 14.19

BRIEF-Jianmin Pharmaceutical Group to sell 52.38 pct stake in Wuhan-based pharma unit

* Says it plans to sell entire 52.38 percent stake in a Wuhan-based pharma subsidiary to an individual for 11 million yuan

04 Jan 2018

BRIEF-Jianmin Pharmaceutical Group to set up traditional Chinese medicine related unit in Wuhan

* Says it plans to invest 1 million yuan to set up a wholly owned traditional Chinese medicine related unit in Wuhan

03 Jan 2018

BRIEF-Jianmin Pharmaceutical Group to invest 17.1 mln yuan in children's medicines research institute

* Says co plans to invest 17.1 million yuan in co's children's medicines research institute

03 Jan 2018

BRIEF-Jianmin Pharmaceutical to invest 100 mln yuan to set up investment JV with partners

* Says it plans to invest 100 million yuan ($15.17 million) to set up investment JV with partners

21 Sep 2017

BRIEF-Regulator halts review of Jianmin Pharmaceutical's share private placement

* Says securities regulator halts review of its share private placement proposal

25 Jul 2017

Earnings vs. Estimates